DEXA Bone Density: How Training and Exercise Change Your T-Score

What Do DEXA T-Scores Actually Mean?

DEXA compares your bone mineral density to the average peak BMD of a healthy young adult of the same sex, expressing the difference in standard deviations. That number is the T-score. A separate Z-score compares you to age-matched peers, which is more useful for identifying secondary causes of bone loss in younger adults.

The World Health Organization defined the diagnostic thresholds in 1994, and those thresholds remain the clinical standard today. Per the WHO Technical Report Series 843, a T-score of -1.0 to -2.5 defines osteopenia, and -2.5 or below defines osteoporosis. These cutoffs were derived from white postmenopausal women and have known limitations when applied to men, younger women, and non-white populations, though they remain the default reference in most clinical software.

T-Score vs. Z-Score: Which One Matters for Your Patient?

For most adults over 50, the T-score drives clinical decision-making. For adults under 50, a Z-score below -2.0 should prompt investigation for secondary causes such as glucocorticoid use, hyperparathyroidism, or malabsorption. The International Society for Clinical Densitometry (ISCD) recommends using Z-scores rather than T-scores in premenopausal women and men under 50.

Sites Measured and Why They Differ

DEXA typically reports density at three sites: lumbar spine (L1-L4), femoral neck, and total hip. The spine often shows earlier change with both bone loss and treatment response because of its higher trabecular bone content. The hip is the more fracture-critical site; femoral neck T-score predicts hip fracture risk more precisely than spine T-score in older adults. Discordance between sites of more than 1.0 T-score unit should prompt a clinical review for artifact or focal disease.

The Physiology of Bone Response to Mechanical Load

Bone is a dynamic tissue that responds to strain. Osteocytes embedded in the bone matrix detect mechanical deformation and signal osteoblasts to form new bone through a pathway involving the Wnt signaling cascade and sclerostin suppression. This is the biological basis for why exercise works and why bed rest or disuse causes rapid bone loss.

For a mechanical stimulus to drive bone formation, it needs to meet three criteria: sufficient strain magnitude, adequate strain rate (fast loading beats slow loading), and novelty (bone habituates to repetitive identical loads). These three criteria explain the exercise prescription hierarchy that follows.

Strain Magnitude: Why Load Matters More Than Duration

A 30-minute walk produces low strain magnitude at the hip and spine. A weighted squat at 80% of one-repetition maximum produces strains that are several times higher. Animal studies using strain gauges implanted in cortical bone showed that as few as 36 high-magnitude loading cycles per day produced near-maximal osteogenic response, while thousands of low-magnitude cycles produced minimal effect. The clinical translation is clear: heavier loads in fewer repetitions outperform light loads in high repetitions for bone stimulus.

Strain Rate: Impact Loading as a Bone Signal

Jumping, bounding, and plyometric movements deliver force rapidly, generating high strain rates independent of external load. This is why gymnastics and volleyball athletes consistently show higher BMD than cyclists and swimmers at equivalent training volumes. A 2015 meta-analysis published in Osteoporosis International found that high-impact exercise produced mean lumbar spine BMD increases of 1.0-3.2% in premenopausal women, while low-impact exercise produced changes not significantly different from control.

Novelty and Variation in Loading Direction

Bone adapts directionally to habitual loads and stops responding to them. Introducing oblique or varied loading directions (lateral hops, multidirectional lunges, rotational deadlifts) recruits different bone surfaces and sustains the adaptive stimulus. This principle is why single-sport athletes sometimes show site-specific bone density asymmetry (dominant arm in tennis players) and why varied compound training produces broader skeletal adaptation than machine-based isolation work.

Resistance Training Protocols with Evidence for BMD Change

Progressive resistance training is the single best-supported exercise modality for increasing or preserving BMD in adults. The evidence base spans multiple randomized controlled trials, several systematic reviews, and at least two large Cochrane analyses.

What the Cochrane Review Found

The 2011 Cochrane review by Howe et al. (Cochrane Database of Systematic Reviews) analyzed 43 randomized controlled trials involving 4,320 participants. Non-impact aerobic exercise had minimal effect on spine or hip BMD. Resistance training produced statistically significant increases in lumbar spine BMD (weighted mean difference +0.85%, 95% CI 0.43 to 1.28, P<0.001). Combined resistance and impact training showed additive effects at both spine and femoral neck sites.

The LIFTMOR Trial: High-Intensity Resistance Training in Osteoporotic Women

The LIFTMOR trial (Watson et al., 2018, Journal of Bone and Mineral Research) randomized 101 postmenopausal women with low bone mass to either high-intensity resistance and impact training (HIIT-RT) or low-intensity home exercise for 8 months. The HIIT-RT group performed deadlifts, overhead presses, and back squats at loads starting at 80-85% of one-repetition maximum, plus drop-landings.

Results: lumbar spine BMD increased by 2.9% in the HIIT-RT group versus 0.6% in controls (between-group difference P<0.001). Femoral neck BMD increased by 0.3% in HIIT-RT versus a loss of 1.9% in controls. No serious adverse events occurred attributable to the high-load protocol. This trial directly challenged the assumption that heavy loading is contraindicated in women with osteopenia or mild osteoporosis.

Minimum Effective Dose for Clinical Practice

Based on LIFTMOR, the ACSM position stand, and the NOF clinical guidelines, a practical minimum effective protocol for BMD preservation includes:

• Frequency: 2-3 sessions per week with at least 48 hours between sessions
• Intensity: 70-85% of one-repetition maximum for major compound lifts
• Volume: 3 sets of 5-8 repetitions per exercise
• Exercises: deadlift, squat variation, hip hinge, overhead press, and at least one impact movement (jump, drop-landing, or weighted step-up with rapid descent)
• Duration before measurable DEXA change: 8-12 months minimum, as bone remodeling cycles take approximately 3-4 months to complete

Aerobic Exercise: Benefits and Limitations for Bone

Running and other weight-bearing aerobic activities do stimulate bone, but the effect is site-specific and modest compared to resistance training. A meta-analysis of 22 RCTs by Zhao et al. (2017, BioMed Research International) found that running produced mean spine BMD increases of 1.68% (95% CI 0.57-2.79%) in postmenopausal women. The hip response was smaller and not consistently significant across trials.

Cycling and swimming, as non-weight-bearing activities, produce no meaningful osteogenic stimulus and should not be counted toward bone-loading exercise volume. Competitive cyclists have been shown in multiple studies to have lower spinal BMD than sedentary age-matched controls, likely due to high training volume crowding out weight-bearing activity combined with high sweat calcium losses.

Running Volume and Bone: The RED-S Caveat

High running volumes in the context of low energy availability, known as relative energy deficiency in sport (RED-S), suppress bone formation through suppression of IGF-1 and elevation of cortisol regardless of mechanical loading. The Female Athlete Triad Coalition consensus statement defines the triad of low energy availability, menstrual dysfunction, and low BMD as a spectrum that can affect male and female athletes. Energy sufficiency is a prerequisite for exercise-induced bone gain.

How Much Can BMD Actually Improve? Setting Realistic Expectations

Adults over 50 should expect preservation of BMD as the primary goal of exercise, with modest gains possible at sites with high trabecular content (lumbar spine). The LIFTMOR trial's 2.9% lumbar spine gain over 8 months represents the upper range of what supervised high-intensity protocols achieve. Most well-designed RCTs in postmenopausal women report spine gains of 1-3% over 12 months with consistent resistance training.

Cortical sites (femoral shaft, radial shaft) respond more slowly. Gains of 0.5-1.5% per year are typical at the femoral neck with combined resistance and impact training. These numbers sound small but are clinically meaningful: a 10-year difference in BMD trajectory translates to a substantial shift in fracture probability on the FRAX calculator.

Age and the Response Ceiling

Premenopausal women and men under 50 show the largest absolute BMD gains because estrogen and testosterone amplify the Wnt-mediated osteoblast response to mechanical loading. Men over 65 and postmenopausal women not on hormone therapy still respond to loading, but the magnitude is attenuated by approximately 30-50% compared to younger adults. This is one reason the Endocrine Society clinical practice guideline on osteoporosis in men recommends combining resistance training with testosterone replacement when hypogonadism accompanies low BMD.

Does Hormone Therapy Amplify Exercise-Induced BMD Gains?

There is reasonable evidence from observational data and small RCTs that estrogen therapy and testosterone therapy each amplify the skeletal response to mechanical loading. The WHI trial showed that combined hormone therapy produced spine BMD gains of 3.7% and hip BMD gains of 3.6% over 3 years compared to placebo, without controlling for exercise. Studies combining exercise with estrogen therapy suggest the effects may be additive rather than purely synergistic, though the RCT evidence for the combination is limited to short-duration trials. The NAMS 2022 position statement supports hormone therapy for skeletal preservation in women under 60 or within 10 years of menopause with appropriate risk-benefit assessment.

When Exercise Is Not Enough: Pharmacotherapy Thresholds

Exercise is a first-line intervention for osteopenia and a mandatory co-intervention alongside drug therapy for osteoporosis. It is not a substitute for pharmacotherapy in high-risk patients.

FRAX and the Treatment Decision

The FRAX tool (available at WHO Collaborating Centre for Metabolic Bone Diseases) calculates 10-year probability of major osteoporotic fracture and hip fracture using T-score, age, sex, and clinical risk factors. The National Osteoporosis Foundation guidelines recommend pharmacological treatment when:

• T-score is at or below -2.5 at the femoral neck or spine, or
• T-score is -1.0 to -2.5 (osteopenia) AND 10-year FRAX probability of major osteoporotic fracture is at or above 20%, or 10-year hip fracture probability is at or above 3%

Alendronate: The First-Line Bisphosphonate

Alendronate 70 mg weekly is the most prescribed bisphosphonate and retains the strongest long-term fracture prevention evidence. The FIT trial (Fracture Intervention Trial, Black et al., New England Journal of Medicine) showed that alendronate reduced vertebral fracture risk by 47% and hip fracture risk by 51% over 3 years in women with prior vertebral fracture and femoral neck T-score below -1.6. Alendronate inhibits osteoclast-mediated resorption rather than stimulating formation, making it mechanistically complementary to resistance training, which drives formation.

Patients on alendronate who maintain progressive resistance training show greater BMD gains than those on drug therapy alone, though large RCTs specifically designed to test this combination are lacking. The combination is routinely recommended by both the American College of Rheumatology and AACE guidelines.

Nutrition as the Foundation Under Exercise

No exercise protocol can compensate for chronic calcium or vitamin D deficiency. The Institute of Medicine reference intakes recommend 1,000-1,200 mg elemental calcium per day from food and supplement sources combined for adults over 50, and 600-800 IU vitamin D daily, with many clinicians supplementing to 1,500-2,000 IU to maintain serum 25-hydroxyvitamin D above 30 ng/mL. A 2022 meta-analysis in The Lancet Diabetes and Endocrinology found that vitamin D supplementation alone did not reduce fracture risk in vitamin D-replete adults, reinforcing that supplementation should target deficiency correction rather than supra-physiologic dosing.

Protein intake supports bone matrix synthesis through collagen production. The anabolic response to resistance training on bone requires adequate protein; current evidence supports 1.2-1.6 g/kg body weight per day for older adults engaged in structured resistance training, per the PROT-AGE Study Group consensus.